TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Tóm tắt
Modern medicine often clashes with traditional medicine such as Chinese herbal medicine because of the little understanding of the underlying mechanisms of action of the herbs. In an effort to promote integration of both sides and to accelerate the drug discovery from herbal medicines, an efficient systems pharmacology platform that represents ideal information convergence of pharmacochemistry, ADME properties, drug-likeness, drug targets, associated diseases and interaction networks, are urgently needed. The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was built based on the framework of systems pharmacology for herbal medicines. It consists of all the 499 Chinese herbs registered in the Chinese pharmacopoeia with 29,384 ingredients, 3,311 targets and 837 associated diseases. Twelve important ADME-related properties like human oral bioavailability, half-life, drug-likeness, Caco-2 permeability, blood-brain barrier and Lipinski’s rule of five are provided for drug screening and evaluation. TCMSP also provides drug targets and diseases of each active compound, which can automatically establish the compound-target and target-disease networks that let users view and analyze the drug action mechanisms. It is designed to fuel the development of herbal medicines and to promote integration of modern medicine and traditional medicine for drug discovery and development. The particular strengths of TCMSP are the composition of the large number of herbal entries, and the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms of action of Chinese herbs, uncovering the nature of TCM theory and developing new herb-oriented drugs. TCMSP is freely available at
http://sm.nwsuaf.edu.cn/lsp/tcmsp.php
.
Tài liệu tham khảo
Cheung F: TCM: made in China. Nature. 2011, 480: S82-S83. 10.1038/480S82a.
Li X, Xu X, Wang J, Yu H, Wang X, Yang H, Xu H, Tang S, Li Y, Yang L, Huang L, Wang Y, Yang S: A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: compound Danshen Formula for Cardiovascular Disease Treatment. PLoS One. 2012, 7: e43918-10.1371/journal.pone.0043918.
Kuruvilla FG, Shamji AF, Sternson SM, Hergenrother PJ, Schreiber SL: Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature. 2002, 416: 653-657. 10.1038/416653a.
Tao W, Xu X, Wang X, Li B, Wang Y, Li Y, Yang L: Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2013, 145: 1-10. 10.1016/j.jep.2012.09.051.
Liu J, Pei M, Zheng C, Li Y, Wang Y, Lu A, Yang L: A Systems-Pharmacology Analysis of Herbal Medicines Used in Health Improvement Treatment: predicting Potential New Drugs and Targets. Evid Based Complement Alternat Med. 2013, 2013: 1-17.
Liu H, Wang J, Zhou W, Wang Y, Yang L: Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J Ethnopharmacol. 2013, 146: 773-793. 10.1016/j.jep.2013.02.004.
Li P, Chen J, Wang J, Zhou W, Wang X, Li B, Tao W, Wang W, Wang Y, Yang L: Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases. J Ethnopharmacol. 2014, 151: 93-107. 10.1016/j.jep.2013.07.001.
Huang C, Zheng C, Li Y, Wang Y, Lu A, Yang L: Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform. 2013, in press
Ma T, Tan C, Zhang H, Wang M, Ding W, Li S: Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol Biosyst. 2010, 6: 613-10.1039/b914024g.
Li S, Zhang B, Zhang N: Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol. 2011, 5: S10-
Wang X, Xu X, Tao W, Li Y, Wang Y, Yang L: A Systems Biology Approach to Uncovering Pharmacological Synergy in Herbal Medicines with Applications to Cardiovascular Disease. Evid Based Complement Alternat Med. 2012, 2012: 1-15.
Chen X, Zhou H, Liu YB, Wang JF, Li H, Ung CY, Han LY, Cao ZW, Chen YZ: Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation. Br J Pharmacol. 2006, 149: 1092-1103.
Chen CY-C: TCM Database@Taiwan: The World’s Largest Traditional Chinese Medicine Database for Drug Screening In Silico. PLoS One. 2011, 6: e15939-10.1371/journal.pone.0015939.
Ehrman TM, Barlow DJ, Hylands PJ: Phytochemical Databases of Chinese Herbal Constituents and Bioactive Plant Compounds with Known Target Specificities. J Chem Inf Model. 2007, 47: 254-263. 10.1021/ci600288m.
Ye H, Ye L, Kang H, Zhang D, Tao L, Tang K, Liu X, Zhu R, Liu Q, Chen YZ, Li Y, Cao Z: HIT: linking herbal active ingredients to targets. Nucleic Acids Res. 2010, 39: D1055-D1059.
Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T: TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 2013, 41: D1089-D1095. 10.1093/nar/gks1100.
Gu J, Gui Y, Chen L, Yuan G, Xu X: CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology. J Cheminformatics. 2013, 5: 51-10.1186/1758-2946-5-51.
Li Q, Cheng T, Wang Y, Bryant SH: PubChem as a public resource for drug discovery. Drug Discov Today. 2010, 15: 1052-1057. 10.1016/j.drudis.2010.10.003.
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP: ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2011, 40: D1100-D1107.
Pence HE, Williams A: ChemSpider: An Online Chemical Information Resource. J Chem Educ. 2010, 87: 1123-1124. 10.1021/ed100697w.
Zhang L, Liu T, Wang X, Wang J, Li G, Li Y, Yang L, Wang Y: Insight into the binding mode and the structural features of the pyrimidine derivatives as human A2A adenosine receptor antagonists. Biosystems. 2014, 115: 13-22.
O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR: Open Babel: An open chemical toolbox. J Cheminformatics. 2011, 3: 33-10.1186/1758-2946-3-33.
Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, Duan J, Ling Y: A Novel Chemometric Method for the Prediction of Human Oral Bioavailability. Int J Mol Sci. 2012, 13: 6964-6982. 10.3390/ijms13066964.
Shen M, Tian S, Li Y, Li Q, Xu X, Wang J, Hou T: Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J Cheminformatics. 2012, 4: 1-13. 10.1186/1758-2946-4-1.
CA L: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997, 23: 3-25. 10.1016/S0169-409X(96)00423-1.
Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for “omics” research on drugs. Nucleic Acids Res. 2011, 39: D1035-D1041. 10.1093/nar/gkq1126.
Yu H, Chen J, Xu X, Li Y, Zhao H, Fang Y, Li X, Zhou W, Wang W, Wang Y: A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data. PLoS One. 2012, 7: e37608-10.1371/journal.pone.0037608.
Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Liu X, Zhang J, Han B, Zhang P, Chen Y: Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2011, 40: D1128-D1136.
Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD: Cytoscape Web: an interactive web-based network browser. Bioinformatics. 2010, 26: 2347-2348. 10.1093/bioinformatics/btq430.
Assenov Y, Ramirez F, Schelhorn S-E, Lengauer T, Albrecht M: Computing topological parameters of biological networks. Bioinformatics. 2007, 24: 282-284.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13: 2498-2504. 10.1101/gr.1239303.
Su X, Kong L, Lei X, Hu L, Ye M, Zou H: Biological Fingerprinting Analysis of Traditional Chinese Medicines with Targeting ADME/Tox Property for Screening of Bioactive Compounds by Chromatographic and MS Methods. Mini-Rev Med Chem. 2007, 7: 87-98. 10.2174/138955707779317830.
Van de Waterbeemd H, Gifford E: ADMET in silico modelling: towards prediction paradise?. Nat Rev Drug Discov. 2003, 2: 192-204. 10.1038/nrd1032.
Li Y, Han C, Wang J, Xiao W, Wang Z, Zhang J, Yang Y, Zhang S, Ai C: Investigation into the mechanism of Eucommia ulmoides Oliv. based on a systems pharmacology approach. J Ethnopharmacol. 2014, 151: 452-460. 10.1016/j.jep.2013.10.067.
Wang X, Xu X, Li Y, Li X, Tao W, Li B, Wang Y, Yang L: Systems pharmacology uncovers Janus functions of botanical drugs: activation of host defense system and inhibition of influenza virus replication. Integr Biol. 2013, 5: 351-10.1039/c2ib20204b.
Yao Y, Zhang X, Wang Z, Zheng C, Li P, Huang C, Tao W, Xiao W, Wang Y, Huang L, Yang L: Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. J Ethnopharmacol. 2013, 150: 619-638. 10.1016/j.jep.2013.09.018.